All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages

Author(s): Z. You, L. Bei, L.P. Cheng and N.S. Cheng

The aim of this study was to investigate the expression and clinical significance of cyclooxygenase 2 (COX-2) and vascular endothelial growth factor C (VEGF-C) in cholangiocarcinomas at different clinical and pathological stages. Eighty cholangiocarcinoma samples of patients treated with surgery between January 2012 and January 2014 were collected. Immunohistochemistry was used to detect COX-2 and VEGF-C expression at different clinical and pathological stages. ELISA, real-time PCR, invasive chambers, and MTT assay were applied in cultured cholangiocarcinoma cells treated with a COX-2 inhibitor. Expression of COX-2 and VEGF-C correlated positively with the clinical TNM stage but did not correlate with the differentiation status. Inhibition of COX-2 activity reduced VEGF-C mRNA expression and secretion in cholangiocarcinoma cells and decreased their migration but not proliferation. Because of its ability to inhibit invasion, COX-2 could be a new target for treatment of cholangiocarcinoma.